Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Scimed's Dispatch

This article was originally published in The Gray Sheet

Executive Summary

Full launch of firm's coronary infusion catheter is scheduled for late summer, Director of Investor Relations Karen Kelsey tells attendees of the Alex. Brown conference in Baltimore May 11. To date, more than 100 of the devices have been used clinically, Kelsey says. The product, which may be used to deliver agents to reduce restenosis, dissolve thrombus, and facilitate revascularization, has been sold on a limited basis since receiving clearance earlier this year ("The Gray Sheet" Jan. 17, p. 8)
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002313

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel